
AI-designed Affinity Reagents
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months. Medium Biosciences is a Y Combinator company (Summer 2021). YC-listed status: Active.